Abstract
MYL-1402O (Abevmy(R), Lextemy(R)) is a biosimilar of the reference anti-vascular endothelial growth factor antibody bevacizumab. Abevmy(R) is approved......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
